ABSI soars 36% on positive interim update from phase I hair loss study
- Posted on June 25, 2026
- By Bing News
- 0 Views
- 1 min read
ABSI soars 36% on positive interim update from phase I hair loss study
Absci ABSI shares surged 36% on Wednesday after the company reported positive interim data from the phase I portion of its ongoing phase I/IIa HEADLINE study evaluating ABS-201, an investigational PRLR antibody for androgenetic alopecia (AGA). Per the early-stage data, the candidate was well tolerated across all evaluated dose levels, and pharmacokinetic data supported the potential for infrequent dosing, providing an encouraging early clinical...
